retatrutide phase 2 nejm weight loss 48 weeks percent Trial of for Obesity Retatrutide just delivered the first

107 These effects all result in a slower and steadier uptake of nutrients into the circulation

Most GLP-1 drugs hit one or two of these

Ein Triple-Agonist, der sowohl GLP-1 und GIP als auch Glukagon-Rezeptoren aktivieren kann (Retatrutide), fhrte nach 48 Wochen zu einer Gewichtsabnahme von 24,2 % mit der hchsten Dosis (12 mg/Woche) (58)

Now that we know signals from the gut to the brain suppress the appetite and help control blood sugar levels, researchers are on the hunt for drug-free triggers

This effect on macrophage infiltration has become one of the most prominent features of GLP-1 receptor agonism, as demonstrated in numerous subsequent experimental studies